Bionano Genomics (BNGO) Set to Announce Quarterly Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO - Get Free Report) is set to release its earnings data after the market closes on Wednesday, May 8th. Persons that are interested in registering for the company's earnings conference call can do so using this link.

Bionano Genomics (NASDAQ:BNGO - Get Free Report) last issued its quarterly earnings results on Tuesday, March 5th. The company reported ($0.96) earnings per share (EPS) for the quarter. The company had revenue of $10.72 million for the quarter. Bionano Genomics had a negative return on equity of 103.68% and a negative net margin of 643.74%. On average, analysts expect Bionano Genomics to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Bionano Genomics Price Performance

NASDAQ:BNGO traded down $0.01 during trading hours on Thursday, reaching $0.95. 935,212 shares of the company were exchanged, compared to its average volume of 1,589,040. The company has a market capitalization of $63.47 million, a P/E ratio of -0.14 and a beta of 2.40. Bionano Genomics has a 1-year low of $0.71 and a 1-year high of $8.20. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.40 and a quick ratio of 1.17. The business has a 50 day moving average of $1.02 and a 200 day moving average of $1.31.


Analyst Upgrades and Downgrades

Separately, Scotiabank reduced their price target on Bionano Genomics from $7.00 to $6.00 and set a "sector outperform" rating on the stock in a research report on Thursday, March 7th.

View Our Latest Analysis on BNGO

Bionano Genomics Company Profile

(Get Free Report)

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

Featured Stories

Earnings History for Bionano Genomics (NASDAQ:BNGO)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Bionano Genomics right now?

Before you consider Bionano Genomics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bionano Genomics wasn't on the list.

While Bionano Genomics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Featured Articles and Offers

Search Headlines: